FDA Adverse Event
Death
Summary report: N
ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2
MDR report key: 1083512
·
Received July 29, 2008
Report
- Report Number
- 2953200-2008-00611
- Event Type
- Death
- Date Received
- July 29, 2008
- Date of Event
- June 29, 2008
- Report Date
- June 30, 2008
- Manufacturer
- MEDTRONIC CARDIOVASCULAR GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
SECONDARY INTERVENTION. EVALUATION CODES: RESULTS: SUBACUTE THROMBOSIS, MI, DEATH.
Description of Event or Problem · 1
FOUR ENDEAVOR MX2 DRUG-ELUTING CORONARY STENTS WERE SUCCESSFULLY IMPLANTED INTO A PATIENT FOR TREATMENT OF A PROXIMAL AND MID RCA; AND A PROXIMAL AND MID CIRCUMFLEX ARTERY. THE VESSEL MORPHOLOGY WAS NOT REPORTED. IT IS UNKNOWN IF THE LESION WAS PRE-DILATED. (MFR REPORT# 2953200-2008-00611-00614) IT WAS REPORTED FIVE DAYS POST STENT IMPLANT THAT THE PATIENT PRESENTED EMERGENTLY TO THE ER WITH SUB ACUTE STENT THROMBOSIS. THE PATIENT WAS REPORTED TO HAVE POBA; THEN WAS TRANSFERRED TO THE ICU. IT WAS REPORTED THAT THE PATIENT EXPIRED THE FOLLOWING DAY. THE PHYSICIAN SUSPECTS THAT THE PATIENT MAY HAVE A PLAVIX RESISTANCE ISSUE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2 | NIQ | MEDTRONIC CARDIOVASCULAR GALWAY | NA | 0000636803 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Death| R | THE PATIENT WAS ON PLAVIX PRIOR TO THE EVENT.| ASA POST PROCEDURE| THE PATIENT WAS PLACED ON PLAVIX AND |